Cardinal Health to Distribute Qiagen MDx Products to Small, Mid-sized US Hospitals | GenomeWeb

NEW YORK (GenomeWeb News) – Qiagen announced after the close of the market on Monday that Cardinal Health will make Qiagen's molecular diagnostics products available to small and mid-sized hospitals in the US not covered by Qiagen's own sales channels.

Based in Dublin, Ohio, Cardinal Health distributes pharmaceuticals and medical products to healthcare providers and has annual sales of $103 billion.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: SNP reference panel from the Haplotype Reference Consortium, and more.

Halloran Consulting's Laurie Halloran lists at Stat News the mistakes she sees startup companies make when pursuing a clinical trial.

MIT researchers are using bees to collect and visualize urban microbiome samples, Wired reports.

Reliance on Excel leads to errors in gene name lists, a new Genome Biology paper reports.